These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, Zeuzem S. Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736 [Abstract] [Full Text] [Related]
3. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade. Wolfort RM, Papillion PW, Turnage RH, Lillien DL, Ramaswamy MR, Zibari GB. Int Surg; 2010 Nov; 95(1):67-75. PubMed ID: 20480845 [Abstract] [Full Text] [Related]
6. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma. Refaat R, Basha MAA, Hassan MS, Hussein RS, El Sammak AA, El Sammak DAEA, Radwan MHS, Awad NM, Saad El-Din SA, Elkholy E, Ibrahim DRD, Saleh SA, Montasser IF, Said H. Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070 [Abstract] [Full Text] [Related]
7. Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma. Song MJ, Bae SH, Yoo IeR, Park CH, Jang JW, Chun HJ, Choi BG, Lee HG, Choi JY, Yoon SK. World J Gastroenterol; 2012 Jul 07; 18(25):3215-22. PubMed ID: 22783045 [Abstract] [Full Text] [Related]
10. Efficiency of whole-body 18F-FDG PET CT in detecting the cause of rising serum AFP level in post-therapeutic follow-up for HCC patients. Ali SA, Amin DH, Abdelkhalek YI. Jpn J Radiol; 2020 May 07; 38(5):472-479. PubMed ID: 32078123 [Abstract] [Full Text] [Related]
11. [Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma]. Kong YH, Han CJ, Lee SD, Sohn WS, Kim MJ, Ki SS, Kim J, Jeong SH, Kim YC, Lee JO, Cheon GJ, Choi CW, Lim SM. Korean J Hepatol; 2004 Dec 07; 10(4):279-87. PubMed ID: 15613803 [Abstract] [Full Text] [Related]
13. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, Yi NJ, Lee KU. Liver Transpl; 2006 Nov 07; 12(11):1655-60. PubMed ID: 16964589 [Abstract] [Full Text] [Related]
14. Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation. Boussouar S, Itti E, Lin SJ, Decaens T, Evangelista E, Chiaradia M, Chalaye J, Baranes L, Calderaro J, Laurent A, Pigneur F, Duvoux C, Azoulay D, Costentin C, Rahmouni A, Luciani A. Cancer Imaging; 2016 Feb 16; 16():4. PubMed ID: 26883745 [Abstract] [Full Text] [Related]
18. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET. Yamamoto Y, Nishiyama Y, Kameyama R, Okano K, Kashiwagi H, Deguchi A, Kaji M, Ohkawa M. J Nucl Med; 2008 Aug 16; 49(8):1245-8. PubMed ID: 18632827 [Abstract] [Full Text] [Related]
19. [Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein]. Chen Z, Liang H, Zhang X, Wang X, Chen W, Shi X, Yi C, Rao L. Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov 16; 32(11):1615-9. PubMed ID: 23174588 [Abstract] [Full Text] [Related]
20. Early prediction of microvascular invasion (MVI) occurrence in hepatocellular carcinoma (HCC) by 18F-FDG PET/CT and laboratory data. Wang T, Chen X, Huang H, Jia N. Eur J Med Res; 2024 Jul 30; 29(1):395. PubMed ID: 39080787 [Abstract] [Full Text] [Related] Page: [Next] [New Search]